Evotec SE (ADR)

General ticker "EVO" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $1.4B (TTM average)

Evotec SE (ADR) follows the US Stock Market performance with the rate: 4.3%.

Estimated limits based on current volatility of 1.7%: low 3.16$, high 3.29$

Factors to consider:

  • Total employees count: 203 as of 2007
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.58$, 5.67$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.31$, 5.15$]

Financial Metrics affecting the EVO estimates:

  • Positive: with PPE of -7.8 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Positive: -14.38 < Investing cash flow per share per price, % of -4.65
  • Negative: negative Industry operating cash flow (median)
  • Positive: 41.86 < Shareholder equity ratio, % of 49.81 <= 63.39
  • Positive: 0.33 < Operating cash flow per share per price, % of 1.19
  • Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15

Similar symbols

Short-term EVO quotes

Long-term EVO plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue €751.45MM €781.43MM €796.97MM
Operating Expenses €730.60MM €828.93MM €939.49MM
Operating Income €20.85MM €-47.51MM €-142.52MM
Non-Operating Income €-174.81MM €-33.09MM €-51.45MM
Interest Expense €13.15MM €11.74MM €11.70MM
R&D Expense €76.64MM €68.53MM €50.86MM
Income(Loss) €-153.96MM €-80.59MM €-193.98MM
Taxes €21.70MM €3.32MM €2.10MM
Profit(Loss)* €-175.66MM €-83.91MM €-196.08MM
Stockholders Equity €1,187.18MM €1,119.91MM €952.52MM
Inventory €29.82MM €30.89MM €31.12MM
Assets €2,257.25MM €2,252.47MM €1,912.50MM
Operating Cash Flow €205.81MM €36.44MM €18.22MM
Capital expenditure €181.35MM €216.00MM €132.24MM
Investing Cash Flow €-412.80MM €-13.29MM €-71.19MM
Financing Cash Flow €-58.15MM €71.96MM €-161.42MM
Earnings Per Share** €-0.50 €-0.24 €-0.55
Ordinary share to ADR 2.00x 2.00x 2.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.